Anchor Therapeutics is Drug Discovery in United States that focus on pharmaceutical platform business. Founded in 2006. They cover business area such as developer, cancer, inflammation, metabolism, heart disease, pain, Pepducin lipopeptide drug candidate, molecule, g protein-couple receptor, GPCRs, allosterically modulate GPCR, healthcare professional, new treatment option, regenerative medicine, diabetes.
2006
( 18 years old in 2024 )
Pharmaceutical Platform
-
One Kendall Square
Building 200, Suite 2203
Cambridge, MA 02139
United States
Private
developercancerinflammationmetabolismheart diseasepainPepducin lipopeptide drug candidatemoleculeg protein-couple receptorGPCRsallosterically modulate GPCRhealthcare professionalnew treatment optionregenerative medicinediabetes
* We use standard office opening hours in near Anchor Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Anchor Therapeutics is Drug Discovery business from United States that founded in 2006 (18 years old in 2024), Anchor Therapeutics business is focusing on Pharmaceutical Platform.
Anchor Therapeutics headquarter office and corporate office address is located in One Kendall Square Building 200, Suite 2203 Cambridge, MA 02139 United States.
Anchor Therapeutics was founded in United States.
In 2024, Anchor Therapeutics is currently focus on pharmaceutical platform sector.
Above is snippet of Google Trends for "pharmaceutical platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Anchor Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.